Safety and Immunogenicity of Prime-Boost Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-002)

NCT02280408 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Ebola Viruses

Interventions

OTHER: Placebo
BIOLOGICAL: V920

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]
[object Object]